Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 351-360 of 11899

Edit search filters
  1. Eosinophilic Esophagitis Pilot Trial of Baked Milk Tolerance

    Rochester, MN

  2. A Study to Evaluate Obinutuzumab to Treat Immunosuppression-dependent or Immunosuppression/Treatment-resistant Focal Segmental Glomerulosclerosis

    Rochester, MN

  3. Submandibular Gland Needle Core Biopsy and Skin Punch Biopsy as Tissue Biomarkers for the Diagnosis and Monitoring of Disease Progression of Parkinson’s Disease and REM Sleep Behavior Disorder

    Scottsdale/Phoenix, AZ

  4. Treatment Of Thumb Carpometacarpal (CMC) Arthritis Using Stablyx® CMC Arthroplasty System

    Rochester, MN

  5. A Study Of R-ICE And Lenalidomide For Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

    Jacksonville, FL, Rochester, MN

  6. Outcomes Of Meniscus Root Repair Using A Transtibial Pullout Technique

    Rochester, MN

  7. Emricasan, An Oral Caspase Inhibitor, In Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis And Severe Portal Hypertension

    Rochester, MN

  8. A Study For Patients Who Completed VITALITY-ALS (CY 4031) VIGOR-ALS

    Jacksonville, FL

  9. A Single Patient Treatment Use Of UX007 For Adult Malonyl-coA Decarboxylase Deficiency

    Rochester, MN

  10. DSC-MRI In Measuring Relative Cerebral Blood Volume For Early Response To Bevacizumab In Patients With Recurrent Glioblastoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer